CCM Duopharma Biotech Bhd (CCMDBIO):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:CCM Duopharma Biotech Bhd (CCMDBIO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3490
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:24
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:マレーシア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
CCM Duopharma Biotech Bhd (CCMD), a subsidiary of Chemical Company of Malaysia Bhd, is a pharmaceutical company that develops, manufactures and markets generic drugs and branded pharmaceutical products. The company offers products in the form of tablets, capsules, syrup, oral antibiotic, creams, haemodialysis solution, sterile irrigation solution, sterile powder injectables, small volume injectables, dental cartridges and eye drop preparations. It also manufactures small volume injectables through its manufacturing facility in Klang. CCMD exports its products across Vietnam, Ethiopia, Sudan, Papua New Guinea, Pakistan, Bangladesh, Sri Lanka, Republic of Yemen, Singapore and Hong Kong. The company operates through its subsidiaries in the Philippines, Indonesia and Singapore. CCM Duopharma is headquartered in Klang, Malaysia.

CCM Duopharma Biotech Bhd (CCMDBIO) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
CCM Duopharma Biotech Bhd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
CCM Duopharma Biotech Bhd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
CCM Duopharma Biotech Bhd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
CCM Duopharma Biotech Bhd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
CCM Duopharma Biotech Bhd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
CCM Duopharma Biotech Bhd, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Duopharma Enters into Agreement with PanGen Biotech 10
Licensing Agreements 11
Biocon Enters Into Licensing Agreement With CCM Pharma For Insulin Products 11
Equity Offering 12
CCM Duopharma Biotech Prices Rights Offering of Shares for USD75 Million 12
Acquisition 13
CCM Duopharma Biotech to Acquire 8.39% Stake in Pangen Biotech from Chemical Company of Malaysia for USD9.4 Million 13
CCM Duopharma Biotech Acquires Six Pharma Units from Chemical Company of Malaysia for USD66.16 Million 15
CCM Duopharma Biotech Bhd – Key Competitors 17
CCM Duopharma Biotech Bhd – Key Employees 18
CCM Duopharma Biotech Bhd – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 21
Financial Announcements 21
Feb 24, 2017: CCM Duopharma Registers Double-Digit Top Line Growth In FY 2016 21
Other Significant Developments 22
May 22, 2017: CCM Duopharma Aims To Become A Leading Regional Player 22
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List of Tables
CCM Duopharma Biotech Bhd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
CCM Duopharma Biotech Bhd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
CCM Duopharma Biotech Bhd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
CCM Duopharma Biotech Bhd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
CCM Duopharma Biotech Bhd, Deals By Therapy Area, 2012 to YTD 2018 8
CCM Duopharma Biotech Bhd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Duopharma Enters into Agreement with PanGen Biotech 10
Biocon Enters Into Licensing Agreement With CCM Pharma For Insulin Products 11
CCM Duopharma Biotech Prices Rights Offering of Shares for USD75 Million 12
CCM Duopharma Biotech to Acquire 8.39% Stake in Pangen Biotech from Chemical Company of Malaysia for USD9.4 Million 13
CCM Duopharma Biotech Acquires Six Pharma Units from Chemical Company of Malaysia for USD66.16 Million 15
CCM Duopharma Biotech Bhd, Key Competitors 17
CCM Duopharma Biotech Bhd, Key Employees 18
CCM Duopharma Biotech Bhd, Subsidiaries 19

List of Figures
CCM Duopharma Biotech Bhd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
CCM Duopharma Biotech Bhd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
CCM Duopharma Biotech Bhd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
CCM Duopharma Biotech Bhd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
CCM Duopharma Biotech Bhd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
CCM Duopharma Biotech Bhd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
CCM Duopharma Biotech Bhd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
CCM Duopharma Biotech Bhd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[CCM Duopharma Biotech Bhd (CCMDBIO):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Aselsan Elektronik Sanayi Ve Ticaret A.S.:企業の戦略・SWOT・財務情報
    Aselsan Elektronik Sanayi Ve Ticaret A.S. - Strategy, SWOT and Corporate Finance Report Summary Aselsan Elektronik Sanayi Ve Ticaret A.S. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • Macquarie Infrastructure Corporation:企業のM&A・事業提携・投資動向
    Macquarie Infrastructure Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Macquarie Infrastructure Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports …
  • Ana Holdings Inc.:戦略・SWOT・企業財務分析
    Ana Holdings Inc. - Strategy, SWOT and Corporate Finance Report Summary Ana Holdings Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Philippine National Bank
    Philippine National Bank - Strategy, SWOT and Corporate Finance Report Summary Philippine National Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Instituto Costarricense de Electricidad:企業の戦略的SWOT分析
    Instituto Costarricense de Electricidad - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and m …
  • Verisante Technology Inc (VRS)-医療機器分野:企業M&A・提携分析
    Summary Verisante Technology Inc (Verisante), develops and commercializes products for the early detection of all forms of skin cancer. The company’s key product offerings include Verisante Aura, Verisante Core and Verisante MSI Camera. The Verisante Aura is used for skin cancer detection, and Veris …
  • Superior Energy Services, Inc.:企業の戦略・SWOT・財務情報
    Superior Energy Services, Inc. - Strategy, SWOT and Corporate Finance Report Summary Superior Energy Services, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Elephant Oil Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Elephant Oil Ltd (Elephant Oil) is an oil and gas company. The company provides services such as exploration and production of oil and natural gas. It provides its exploration services in the underexplored areas of West Africa. Elephant Oil holds interest in a production-sharing contract in …
  • Vycor Medical Inc (VYCO):企業の財務・戦略的SWOT分析
    Summary Vycor Medical Inc (Vycor) is a medical device company that develops, designs, and markets medical devices for use in neurosurgery. The company offers computer-based light stimulation therapies for patients suffering from vision loss resulting from neurological trauma such as stroke. It provi …
  • University of Oxford-製薬・医療分野:企業M&A・提携分析
    Summary University of Oxford (UO) is a research and educational university that offers student training, academic research and graduation programs. The university offers graduation courses in the various fields such as humanities, mathematical, physical and life sciences; medical sciences, and conti …
  • Westar Energy Inc (WR):電力:M&Aディール及び事業提携情報
    Summary Westar Energy, Inc. (Westar Energy) is a vertically integrated energy utility that generates, transmits and distributes electricity. The company owns and operates a generation portfolio of coal-fired, nuclear, natural gas-based, renewable and diesel-based power plants. It also procures elect …
  • Axalta Coating Systems Ltd:企業の戦略・SWOT・財務情報
    Axalta Coating Systems Ltd - Strategy, SWOT and Corporate Finance Report Summary Axalta Coating Systems Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Anglo American Platinum Ltd:企業の戦略・SWOT・財務情報
    Anglo American Platinum Ltd - Strategy, SWOT and Corporate Finance Report Summary Anglo American Platinum Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • National Aerospace Fasteners Corporation:企業の戦略・SWOT・財務情報
    National Aerospace Fasteners Corporation - Strategy, SWOT and Corporate Finance Report Summary National Aerospace Fasteners Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Sorrento Therapeutics Inc (SRNE):企業の財務・戦略的SWOT分析
    Sorrento Therapeutics Inc (SRNE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Klaria Pharma Holding AB (KLAR):製薬・医療:M&Aディール及び事業提携情報
    Summary Klaria Pharma Holding AB (Klaria Pharma) is a developer of fast acting medicinal products that designes, develops and commercializ therapeutics for migraine and cancer related pain. The company’s patented drug delivery platform is an alginate-based polymer film, facilitates quick and dependa …
  • Oryzon Genomics SA (ORY):企業の財務・戦略的SWOT分析
    Summary Oryzon Genomics SA (Oryzon) is a clinical stage biopharmaceutical company that offers discovers and develops epigenetic therapies to treat oncology and neurodegenerative diseases. The company offers epigenetics, a regulatory system that controls gene expression without affecting the makeup o …
  • AviChina Industry & Technology Co., Ltd. (2357):企業の財務・戦略的SWOT分析
    AviChina Industry & Technology Co., Ltd. (2357) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key st …
  • Hanesbrands Inc (HBI):企業の財務・戦略的SWOT分析
    Hanesbrands Inc (HBI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Murree Brewery Co. Ltd.:企業の戦略・SWOT・財務分析
    Murree Brewery Co. Ltd. - Strategy, SWOT and Corporate Finance Report Summary Murree Brewery Co. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆